- Home
- MOBX vs MBOT Comparison
MOBX vs MBOT Comparison
Compare MOBX & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOBX
- MBOT
- Stock Information
- Founded
- MOBX 2020
- MBOT 2010
- Country
- MOBX United States
- MBOT United States
- Employees
- MOBX N/A
- MBOT N/A
- Industry
- MOBX
- MBOT Medical/Dental Instruments
- Sector
- MOBX
- MBOT Health Care
- Exchange
- MOBX Nasdaq
- MBOT Nasdaq
- Market Cap
- MOBX 29.9M
- MBOT 32.7M
- IPO Year
- MOBX N/A
- MBOT N/A
- Fundamental
- Price
- MOBX $1.66
- MBOT $1.99
- Analyst Decision
- MOBX
- MBOT Strong Buy
- Analyst Count
- MOBX 0
- MBOT 1
- Target Price
- MOBX N/A
- MBOT $7.00
- AVG Volume (30 Days)
- MOBX 939.6K
- MBOT 7.1M
- Earning Date
- MOBX 02-18-2025
- MBOT 11-13-2024
- Dividend Yield
- MOBX N/A
- MBOT N/A
- EPS Growth
- MOBX N/A
- MBOT N/A
- EPS
- MOBX N/A
- MBOT N/A
- Revenue
- MOBX $6,442,000.00
- MBOT N/A
- Revenue This Year
- MOBX N/A
- MBOT N/A
- Revenue Next Year
- MOBX N/A
- MBOT N/A
- P/E Ratio
- MOBX N/A
- MBOT N/A
- Revenue Growth
- MOBX 426.31
- MBOT N/A
- 52 Week Low
- MOBX $0.55
- MBOT $0.82
- 52 Week High
- MOBX $3.62
- MBOT $3.38
- Technical
- Relative Strength Index (RSI)
- MOBX 57.51
- MBOT 59.53
- Support Level
- MOBX $1.13
- MBOT $1.59
- Resistance Level
- MOBX $1.34
- MBOT $1.91
- Average True Range (ATR)
- MOBX 0.21
- MBOT 0.44
- MACD
- MOBX -0.03
- MBOT -0.01
- Stochastic Oscillator
- MOBX 80.28
- MBOT 39.57
About MOBX Mobix Labs Inc.
Mobix Labs Inc is a fabless semiconductor company developing disruptive next generation wireless and connected solutions that are designed to cater to a broad range of applications in markets including 5G infrastructure, satellite communications, automotive, consumer electronics, e-mobility, healthcare, infrastructure and defense.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.